Small Molecule Therapeutics

all catalysts(0)

nothing on the calendar yet

News(2)

• Roche inks up to $2B deal with Atavistik for new cardiometabolic drugs
  The new partnership follows Roche’s recent R&D expansion in Boston focused on development for cardiovascular, renal and metabolic diseases.
  biospace · 9d ago
• Growth mode: 3 biotechs that are staffing up after series B raises
  Biotechs that announced series B financing this year and are expanding their workforces include one that raised $2.1 billion and has partnerships with Eli Lilly, Johnson & Johnson and Novartis.
  biospace · 9d ago